A. Grahn

发表

Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel

M. Fishman, A. Tan, E. Rubin, 2008, Clinical Cancer Research.

Final results of a Phase I study of Liposome Entrapped Paclitaxel (LEP-ETU) in patients with advanced cancer

M. Fishman, E. Rubin, C. Lauay, 2005 .

What Is the Relationship Between Morning Symptoms and Measures of Disease Activity in Patients With Rheumatoid Arthritis?

M. Boers, J. Kirwan, F. Buttgereit, 2015, Arthritis care & research.

Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans.

T. Rabelink, M. Verhaar, R. Padley, 2000, British journal of clinical pharmacology.

Suitability of the dog as an animal model for evaluating theophylline absorption and food effects from different formulations

K. Kowalski, A. Karim, G. Schoenhard, 1990 .

Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy—a proof of concept analysis

R. Holt, D. Jung, D. Peura, 2014, Journal of drug assessment.

Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience

S. Eastman, K. Bankiewicz, M. Luz, 2009, Journal of Neuro-Oncology.

Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.

Mitchel S Berger, Christoph Pedain, Raj K Puri, 2006, Neurosurgical focus.

CONVECTION‐ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN‐13‐PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS: PHASE 1 STUDY OF FINAL SAFETY RESULTS

Raj K Puri, Susan M. Chang, Michael A Vogelbaum, 2007, Neurosurgery.

Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis

R. Holt, F. Buttgereit, P. Rice, 2015, RMD Open.

Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone

R. Holt, F. Buttgereit, P. Rice, 2015, Scandinavian journal of rheumatology.

Risk of Upper Gastrointestinal Ulcers in Patients With Osteoarthritis Receiving Single-Tablet Ibuprofen/Famotidine Versus Ibuprofen Alone: Pooled Efficacy and Safety Analyses of Two Randomized, Double-Blind, Comparison Trials

R. Holt, P. Rice, J. Kent, 2014, Postgraduate medicine.

Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers

L. Laine, M. Schiff, A. Kivitz, 2011, The American Journal of Gastroenterology.

One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia

R. Holt, J. Kent, J. Ball, 2015, Current medical research and opinion.

One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension

R. Holt, J. Kent, J. Ball, 2015, Current medical research and opinion.

Long Term Safety of an NSAID With Built-in Gastroprotection for Treatment of Pain and Inflammation Related to Oa and RA: Comparative Results From Blinded and Open Label One Year Safety Trials of a Single-Tablet Combination of Ibuprofen-Famotidine

Stanley N Cohen, A. Kivitz, J. Ball, 2011 .

T1137 HZT-501, a Novel Combination Tablet of Ibuprofen and Famotidine, Provides Pharmacokinetics Comparable to Commercially Available Ibuprofen in a Patient-Friendly Dosing Form: Evaluation in Healthy Subjects

D. Jung, J. Sherman, T. Walbert, 2010 .

Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib

R. Holt, J. Kent, A. Grahn, 2015, The Physician and sportsmedicine.

Randomized, double‐blind, placebo‐controlled study of interferon‐γ 1b in Friedreich Ataxia

S. Subramony, S. Perlman, K. Mathews, 2019, Annals of clinical and translational neurology.

Effect of exogenous interferon-gamma (IFN-gamma) on peripheral blood immune markers as part of a phase I clinical trial of combined IFN-gamma with nivolumab (Nivo) in patients (pts) with select solid tumors.

E. Plimack, H. Borghaei, M. Zibelman, 2017 .

CLINICAL FOCUS: RHEUMATOLOGY, PAIN MANAGEMENT AND CONCUSSION GUIDELINES ORIGINAL RESEARCH Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib

R. Holt, J. Kent, A. Grahn, 2015 .